The NCRI Upper Gastrointestinal Group brings together clinicians, scientists and patients, carers and others affected by cancer (also known as ‘consumers’), amongst many others, to coordinate the development of a strategic portfolio of research within the field of upper gastrointestinal cancer. The group works closely with clinical research networks, funders and researchers to develop research to improve outcomes for upper gastrointestinal cancer patients.  

The NCRI Upper Gastrointestinal Group consists of an executive group, chaired by Professor John Bridgewaterwhich provides oversight of the research landscape and proactively identifies opportunities for the group. The NCRI Upper Gastrointestinal Group also has several subgroups that develop research in areas of strategic need. Members are competitively recruited to the executive group and subgroups twice a year.  

Group Chair: Professor John Bridgewater

Alan Anthoney, Leeds Teaching Hospitals NHS Trust – Leeds General Infirmary

John Bridgewater, Professor in medical oncology, UCL Cancer Institute

Pippa Corrie, Consultant medical oncologist, Addenbrooke’s Hospital NHS Foundation Trust

Thomas Crosby, Clinical Director and Consultant Clinical Oncologist, Velindre Cancer Centre

Caroline Dalton, Research Programme Manager, Cancer Research UK (CRUK)

Lesley Goodburn, Consumer Rep, National Cancer Research Institute (NCRI)

Teresa Lockett, RDM, NIHR Clinical Research Network – Thames Valley & South Midlands

Hassan Malik, Aintree University Hospital

Christopher Peters, Clinical Senior Lecturer & Consultant Upper GI Surgeon, Imperial College London